|
⚲
|
| Keyboard |
| Versant Venture Capital VI LP
✚
|
|
|---|---|
| CIK # | 0001687880 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001687880] | |
| 4 | [0001687880] | |
| D | [0001687880] | |
| SC 13D | [0001687880] | |
| SC 13G | [0001687880] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
LENZ Therapeutics Inc LENZ
Common Stock
|
2025-09-30 | Sell | 123 | $47.01 | 5,782 |
|
LENZ Therapeutics Inc LENZ
Common Stock
|
2025-09-30 | Sell | 177 | $47.01 | 8,321 |
|
LENZ Therapeutics Inc LENZ
Common Stock
|
2025-09-30 | Sell | 57,502 | $46.41 | 2,668,668 |
|
LENZ Therapeutics Inc LENZ
Common Stock
|
2025-09-30 | Sell | 49,701 | $45.35 | 2,253,940 |
|
LENZ Therapeutics Inc LENZ
Common Stock
|
2025-09-30 | Sell | 34,405 | $45.35 | 1,560,267 |
|
LENZ Therapeutics Inc LENZ
Common Stock
|
2025-09-30 | Sell | 83,066 | $46.41 | 3,855,093 |
|
LENZ Therapeutics Inc LENZ
Common Stock
|
2025-08-18 | Sell | 15,085 | $38.56 | 581,678 |
|
LENZ Therapeutics Inc LENZ
Common Stock
|
2025-08-18 | Sell | 30,628 | $38.56 | 1,181,016 |
|
LENZ Therapeutics Inc LENZ
Common Stock
|
2025-08-15 | Sell | 145,051 | $39.50 | 5,729,514 |
|
LENZ Therapeutics Inc LENZ
Common Stock
|
2025-08-15 | Sell | 69,949 | $39.50 | 2,762,986 |
|
LENZ Therapeutics Inc LENZ
Common Stock
|
2025-07-10 | Sell | 191,376 | $34.00 | 6,506,784 |
|
LENZ Therapeutics Inc LENZ
Common Stock
|
2025-06-27 | Sell | 200,000 | $30.47 | 6,094,000 |
|
LENZ Therapeutics Inc LENZ
Common Stock
|
2025-06-20 | Sell | 100,877 | $30.35 | 3,061,617 |
|
LENZ Therapeutics Inc LENZ
Common Stock
|
2025-06-20 | Sell | 133,924 | $30.25 | 4,051,201 |
|
LENZ Therapeutics Inc LENZ
Common Stock
|
2025-06-18 | Sell | 100,000 | $29.95 | 2,995,000 |
|
LENZ Therapeutics Inc LENZ
Common Stock
|
2025-06-10 | Sell | 350,000 | $29.00 | 10,150,000 |
|
Monte Rosa Therapeutics Inc GLUE
Common Stock
|
2024-10-29 | Sell | 15,600 | $9.41 | 146,796 |
|
Monte Rosa Therapeutics Inc GLUE
Common Stock
|
2024-10-29 | Sell | 52,305 | $9.08 | 474,929 |
|
Monte Rosa Therapeutics Inc GLUE
Common Stock
|
2024-10-28 | Other | 366,590 | $0.00 | |
|
Monte Rosa Therapeutics Inc GLUE
Common Stock
|
2024-10-28 | Other | 5,499 | $0.00 | |
| showing 20 of 200 most recent transactions | |||||